4 Wealth Advisors, Inc. Abb Vie Inc. Transaction History
4 Wealth Advisors, Inc.
- $98.4 Billion
- Q2 2025
A detailed history of 4 Wealth Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, 4 Wealth Advisors, Inc. holds 2,984 shares of ABBV stock, worth $590,981. This represents 0.56% of its overall portfolio holdings.
Number of Shares
2,984
Previous 2,997
0.43%
Holding current value
$590,981
Previous $628 Million
11.79%
% of portfolio
0.56%
Previous 0.68%
Shares
3 transactions
Others Institutions Holding ABBV
# of Institutions
4,249Shares Held
1.27BCall Options Held
16.5MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA174MShares$34.4 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$27 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.8 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.8 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$8.15 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $350B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...